Physician profile
Ashley Hoffman
NPI 1629667407
$1,214.61
in general payments reported to CMS, 2019-2025
15 companies · $796 in 2025
The $796 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.60 · 2023: $30.31 · 2024: $374 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $471.48 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $310.74 | 2024-2025 | Breztri, Airsupra, Tezspire |
| Genzyme Corporation | $121.98 | 2024-2025 | |
| Scpharmaceuticals INC. | $104.29 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $39.90 | 2024-2025 | Dupixent |
| Grifols USA, LLC | $23.25 | 2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $19.29 | 2025 | Aralast |
| Avadel Cns Pharmaceuticals, LLC | $16.96 | 2024 | Lumryz |
| Jazz Pharmaceuticals INC. | $16.60 | 2024 | |
| Verona Pharma, INC. | $16.17 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $15.99 | 2025 | Sunosi |
| Philips North America LLC | $15.81 | 2024 | (Ak6) Vest Therapy |
| Ani Pharmaceuticals, INC. | $15.10 | 2025 | Purified Cortrophin Gel |
| Novo Nordisk INC | $13.60 | 2022 | |
| Electromed, INC. | $13.45 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.